John Anish M. 4
4 · Oncocyte Corp · Filed Jun 15, 2022
Insider Transaction Report
Form 4
John Anish M.
SVP, Finance, and Interim CFO
Transactions
- Award
Option to Purchase Common Stock
2022-06-01+50,000→ 50,000 totalExercise: $0.99Exp: 2022-06-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.